Evidence map›Paper›PMID 30506101›Full record

ArticleJournal of materials science. Materials in medicine2018

Bio-inspired melanin nanoparticles induce cancer cell death by iron adsorption.

James Perring, Felicity Crawshay-Williams, Cindy Huang, Helen E Townley

Open access · hybridAbstract read
In one paragraph

Article in Journal of materials science. Materials in medicine, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.5field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 16 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

James PerringDepartment of Medical Sciences, Oxford University, Oxford, Oxfordshire, UK.
Felicity Crawshay-WilliamsDepartment of Women's and Reproductive Health, Oxford University, Oxford, Oxfordshire, UK.
Cindy HuangDepartment of Women's and Reproductive Health, Oxford University, Oxford, Oxfordshire, UK.
Helen E TownleyDepartment of Women's and Reproductive Health, Oxford University, Oxford, Oxfordshire, UK. Helen.Townley@eng.ox.ac.uk.
University of Oxford · GBOxford Fertility · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Dysregulation of iron metabolism is a common characteristic of cancer cells. The rapid proliferation of the tumour cells means that there is an increased dependence upon iron compared to healthy cells. Chelation of iron can be undertaken with a number of different compounds, however, simply lowering systemic iron levels to control tumour growth is not possible since iron is essential for cellular metabolism in the rest of the body. Nanoparticulate iron chelators could overcome this difficulty by targeting to the tumour either by the passive enhanced permeation and retention effect, or by targeting ligands on the surface. Nanoparticles were prepared from melanin, which is a naturally occurring pigment that is widely distributed within the body, but that can chelate iron. The prepared nanoparticles were shown to be ~220 nm, and could adsorb 16.45 mmoles iron/g melanin. The nanoparticles showed no affect on control fibroblast cells at a concentration of 200 μM, whereas the immortalised cancer cell lines showed at least 56% reduction in cell growth. At a concentration of 1 mM melanin nanoparticles the cell growth could be reduced by 99% compared to the control. The nanoparticles also show no significant haemotoxicity, even at concentration of 500 μM. Melanin nanoparticles are therefore a viable prospect for destroying cancer cells via iron starvation.

Indexed as

AnimalsCell Line, TumorCell SurvivalDeferoxamineFibroblastsHumansIronIron Chelating AgentsMelaninsNanoparticlesDeferoxamineIronIron Chelating AgentsMelanins

Identifiers

PMID30506101
PMCPMC6267116
OpenAlexW2903255454

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.